News
GoodRx Holdings, Inc.'s partnership with Novo Nordisk highlights its vital role in direct-to-consumer drug pricing. Click ...
Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through ...
Patients who are prescribed Wegovy or Ozempic can now use GoodRx to access the medications at just $499 a month if they skip ...
GoodRx Holdings Inc. (NASDAQ:GDRX) announced that, via a collaboration with Novo Nordisk A/S (NYSE:NVO), all strengths of ...
Detailed price information for Goodrx Holdings Inc Cl A (GDRX-Q) from The Globe and Mail including charting and trades.
Bloomberg on MSN4h
GoodRx Expands Access to Ozempic
GoodRx shares soar after announcing the company's partnership with Novo Nordisk to slash the cost of Ozempic. GoodRx CEO ...
Meta (META) stock is dipping on reports that the company is restructuring its artificial intelligence (AI) unit for the ...
GoodRx reports a summer spike in demand for epinephrine auto-injectors as students prepare for school, worsening current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results